On 12 May 2016 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose only a reprimand on the Athlete Suji S. Rani after she tested positive for the prohibited substance Terbutaline.
Here the Disciplinary Panel accepted that the Athlete established how the substance entered her system and that the violation was not intentional as a result of prescribed medication she had used.
Hereafter the India National Anti-Doping Agency appealed the First Instance Decision of 12 May 2016 with the Anti-Doping Appeal Panel of India (ADAPI). The Agency argued that the Athlete failed in her duty that no prohibited substance entered her system and requested the Appeal Panel to impose a more severe sanction on the Athlete.
The Panel confirms the conclusion of the Disciplinary Panel in First Instance that the Athlete didn’t use a performance enhancing substance and reasonable could not be aware of the risk she would face in consuming a cough syrup which she mentioned on the Doping Control Form. The Appeal Panel finds that a reprimand was a proportional sanction since the violation was not intentional.
Therfore on 12 January 2019 the Anti-Doping Apeal Panel of India decides to dismiss the appeal of the India National Anti-Doping Agency and to uphold the ADDPI decision of 12 May 2016.
